Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Chengxin Group is a large Chinese fine chemical manufacturing company based in Shijiazhuang, Hebei Province. The company is best known as one of China’s largest producers of sodium cyanide and related cyanide derivatives, and it also manufactures cyanuric chloride, benzyl cyanide, phenylacetic acid derivatives, malonate products, cyanoacetate esters, and EDTA chelating agents. Its business appears to focus on industrial chemicals, pesticide intermediates, and pharmaceutical/chemical intermediates rather than drug discovery or therapeutic product development. Although some subsidiaries have pharmaceutical-chemical manufacturing activities, the group overall is not primarily a biotech, pharma, or healthcare company. It operates established production, logistics, and sales infrastructure and appears to be a large-scale active commercial enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Chengxin Group.